These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19775424)

  • 1. The economics of treating stroke as an acute brain attack.
    Bogousslavsky J; Paciaroni M
    BMC Med; 2009 Sep; 7():51. PubMed ID: 19775424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.
    Demaerschalk BM; Yip TR
    Stroke; 2005 Nov; 36(11):2500-3. PubMed ID: 16224087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2016 Mar; 1(1):8-15. PubMed ID: 27547449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial.
    Simpson KN; Simpson AN; Mauldin PD; Hill MD; Yeatts SD; Spilker JA; Foster LD; Khatri P; Martin R; Jauch EC; Kleindorfer D; Palesch YY; Broderick JP;
    Stroke; 2014 Jun; 45(6):1791-8. PubMed ID: 24876261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
    Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
    Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the Nationwide Inpatient Sample Database, 2002 to 2007.
    Hoh BL; Chi YY; Waters MF; Mocco J; Barker FG
    Stroke; 2010 Oct; 41(10):2323-8. PubMed ID: 20724715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of optimizing acute stroke care services for thrombolysis.
    Penaloza-Ramos MC; Sheppard JP; Jowett S; Barton P; Mant J; Quinn T; Mellor RM; Sims D; Sandler D; McManus RJ;
    Stroke; 2014 Feb; 45(2):553-62. PubMed ID: 24385272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of thrombolytic treatment for stroke.
    Mar J; Begiristain JM; Arrazola A
    Cerebrovasc Dis; 2005; 20(3):193-200. PubMed ID: 16088115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Ischemic Stroke (AIS) patient management in French stroke units and impact estimation of thrombolysis on care pathways and associated costs.
    Schmidt A; Heroum C; Caumette D; Le Lay K; Bénard S
    Cerebrovasc Dis; 2015; 39(2):94-101. PubMed ID: 25660476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
    Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
    Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of transfer status on hospitalization cost and discharge disposition for acute ischemic stroke across the US.
    Sonig A; Lin N; Krishna C; Natarajan SK; Mokin M; Hopkins LN; Snyder KV; Levy EI; Siddiqui AH
    J Neurosurg; 2016 May; 124(5):1228-37. PubMed ID: 26452123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?
    Liberman AL; Choi HJ; French DD; Prabhakaran S
    Stroke; 2019 Feb; 50(2):463-468. PubMed ID: 30572813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the efficiency of local versus central provision of intravenous thrombolysis after acute ischemic stroke.
    McMeekin P; Gray J; Ford GA; Rodgers H; Price CI
    Stroke; 2013 Nov; 44(11):3114-9. PubMed ID: 23982716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.
    Fagan SC; Morgenstern LB; Petitta A; Ward RE; Tilley BC; Marler JR; Levine SR; Broderick JP; Kwiatkowski TG; Frankel M; Brott TG; Walker MD
    Neurology; 1998 Apr; 50(4):883-90. PubMed ID: 9566367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada.
    Yip TR; Demaerschalk BM
    Stroke; 2007 Jun; 38(6):1952-5. PubMed ID: 17478740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hospitalization after TIA cost-effective on the basis of treatment with tPA?
    Nguyen-Huynh MN; Johnston SC
    Neurology; 2005 Dec; 65(11):1799-801. PubMed ID: 16344525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic impact of an alternative workflow process for stroke.
    Gilbert BW; Huffman JB; Slechta J; Porter C; Gallagher JM
    Am J Emerg Med; 2019 Feb; 37(2):294-297. PubMed ID: 30442431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.
    Boudreau DM; Guzauskas GF; Chen E; Lalla D; Tayama D; Fagan SC; Veenstra DL
    Stroke; 2014 Oct; 45(10):3032-9. PubMed ID: 25190439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.